Daniel Cohen
Associate Principal Scientist, Protein Chemistry, Lytica Therapeutics
Enrollment Year - 2013
Walensky Lab - Dana-Farber Cancer Institute
Advisor: Loren Walensky
Dissertation Title: Nonenzymatic Cysteine Modification Regulates Pro-Apoptotic BAX